
RBM39 promotes hepatocellular carcinoma (HCC) progression through alternative splicing. High-throughput transcriptome sequencing identified RBM39 as a key splicing factor in HCC, regulating RFX1 exon 2 splicing. This leads to a truncated RFX1 that fails to repress oncogenic collagen genes, activating the FAK/PI3K/AKT pathway. Silencing RBM39 reduced proliferation, migration, and invasion, highlighting its role in HCC and its potential as a therapeutic target.
Like
Save
Share